Entidad De Financiamiento | Compromisos |
---|---|
IDA Credit | 20.00 |
P173861
Closed
Nicolas Collin Dit De Montesson , Courtney Ivins
Republic of Honduras
9 de abril de 2020
(a partir de la presentación ante el Directorio)
15 de abril de 2020
28 de mayo de 2020
US$ 20.00 millones
Ministry of Health (SESAL)
2020
US$ 20.00 millones
N/A
Substantial
31 de octubre de 2024
No
BANK APPROVED
25 de abril de 2024
Entidad De Financiamiento | Compromisos |
---|---|
IDA Credit | 20.00 |
Línea de productos | BIRF/AIF |
---|---|
Compromiso del BIRF | No Disponible |
Compromiso de la AIF | 20.00 |
Compromiso del BIRF + AIF | 20.00 |
Instrumento de Financiamiento | |
---|---|
Monto a título de donación | No Disponible |
Costo total del proyecto** | 20.00 |
Name | Review | Date |
---|---|---|
Progress towards achievement of PDO | Highly Satisfactory | 2025-01-28 |
Procurement | Satisfactory | 2025-01-28 |
Project Management | Satisfactory | 2025-01-28 |
Financial Management | Satisfactory | 2025-01-28 |
Monitoring and Evaluation | Satisfactory | 2025-01-28 |
Overall Implementation Progress (IP) | Satisfactory | 2025-01-28 |
INDICATOR | LÍNEA DE REFERENCIA | EN CURSO | OBJETIVO |
---|
Designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents | Valor | 0.00 | 1.00 | 1.00 |
Fecha | 1 de abril de 2020 | 8 de diciembre de 2023 | 31 de marzo de 2022 | |
Comentar |
ICU beds in prioritized ICU units that are fully equipped and operational | Valor | 0.00 | 92.00 | 70.00 |
Fecha | 1 de abril de 2020 | 8 de diciembre de 2023 | 31 de marzo de 2022 | |
Comentar |
Percentage of population vaccinated, which is included in the priority population targets, as defined in the National Plan for the Introduction of the Vaccine against COVID-19 | Valor | 0.00 | 73.00 | 65.00 |
Fecha | 8 de febrero de 2021 | 8 de diciembre de 2023 | 31 de octubre de 2024 | |
Comentar |
Percentage of female population vaccinated, which is included in the priority population targets, as defined in the National Plan for the Introduction of the Vaccine against COVID-19 | Valor | 0.00 | 66.00 | 65.00 |
Fecha | 8 de febrero de 2021 | 3 de marzo de 2023 | 31 de octubre de 2024 | |
Comentar |
INDICATOR | LÍNEA DE REFERENCIA | EN CURSO | OBJETIVO |
---|
Share of prioritized health facilities receiving the volume of PPEs planned under the project | Valor | 0.00 | 100.00 | 100.00 |
Fecha | 9 de febrero de 2021 | 8 de diciembre de 2023 | 31 de marzo de 2023 | |
Comentar |
Health management and information system to deploy the COVID-19 vaccine is in place, including functionality for identification, registration, and follow-up with COVID-19 vaccine recipients | Valor | No | No | Yes |
Fecha | 8 de febrero de 2021 | 7 de diciembre de 2023 | 31 de octubre de 2024 | |
Comentar |
Share of vaccination leadership roles created by project financing filled by women | Valor | 0.00 | 64.00 | 60.00 |
Fecha | 8 de febrero de 2021 | 7 de diciembre de 2023 | 31 de marzo de 2023 | |
Comentar |
Share of regional health authorities reports on corrective measures taken based on feedback from users of health facilities offering COVID-19 vaccination services published on SESAL's website | Valor | 0.00 | 100.00 | 100.00 |
Fecha | 8 de febrero de 2021 | 7 de diciembre de 2023 | 31 de marzo de 2023 | |
Comentar |